Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Merck Sharp & Dohme LLC, covering 2015-03-23 to 2016-12-12. Get the full timeline:
Most recent: Clinical Trial Update: An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153) [Phase 3]